Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-25 @ 4:01 PM
NCT ID: NCT01095757
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01095757
Study Brief: Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Plerixafor + Chemo and G-CSF Patients who receive a combination of Plerixafor, chemotherapy and G-CSF. Plerixafor : 240 µg/kg subcutaneous injection on the day that the ANC is \> 1500/mm3 and on each day of apheresis for a total of 4 aphereses or the target CD34 cell dose has been reached. None None 0 45 29 45 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea None Gastrointestinal disorders None View
Bone Pain None Musculoskeletal and connective tissue disorders None View
Diarrhea None Gastrointestinal disorders None View
Fatigue None General disorders None View
Hypokalemia None Blood and lymphatic system disorders None View
Lightheadedness None General disorders None View
Headache None General disorders None View
Thrombocytopenia Grade 1/2 None Blood and lymphatic system disorders None View
Thrombocytopenia Over Grade 2 None Blood and lymphatic system disorders None View
Anemia None Blood and lymphatic system disorders None View